Aspaveli (pegcetacoplan) approved in Europe for use among treatment naïve adult patients with PNH – Sobi
Sobi has announced that the European Commission (EC) has approved an indication extension for Aspaveli (pegcetacoplan) for treatment of adult patients with paroxysmal nocturnal haemoglobinuria (PNH) who have… read more.
